Park Ha Biological Technology Appoints New Independent Director
Ticker: BYAH · Form: 6-K · Filed: Jan 7, 2025 · CIK: 1986247
Sentiment: neutral
Topics: director-appointment, corporate-governance
TL;DR
Park Ha Bio Tech adds Da Yang as independent director on Jan 7, 2025.
AI Summary
Park Ha Biological Technology Co., Ltd. announced on January 7, 2025, the appointment of Da Yang as an independent director. The company is based in Wuxi, Jiangsu Province, People's Republic of China, and operates in the soap, detergent, cleaning preparations, perfumes, and cosmetics sector.
Why It Matters
The appointment of a new independent director can signal changes in corporate governance or strategic direction, potentially impacting investor confidence and company oversight.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a director appointment and does not contain significant financial or operational changes.
Key Players & Entities
- Park Ha Biological Technology Co., Ltd. (company) — Registrant
- Da Yang (person) — Appointed Independent Director
- January 7, 2025 (date) — Date of Board Approval and Appointment
FAQ
Who was appointed as an independent director for Park Ha Biological Technology Co., Ltd.?
Da Yang was appointed as an independent director.
On what date was the appointment of the new independent director approved?
The Board approved the appointment on January 7, 2025.
What is the principal executive office address of Park Ha Biological Technology Co., Ltd.?
The address is 901 & 901-2, Building C Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, People's Republic of China, 214000.
What is the SIC code for Park Ha Biological Technology Co., Ltd.?
The SIC code is 2840, which corresponds to SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS.
Does Park Ha Biological Technology Co., Ltd. file annual reports under Form 20-F or Form 40-F?
The registrant indicates it files annual reports under cover of Form 20-F.
Filing Stats: 475 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2025-01-07 16:00:29
Filing Documents
- ea0226874-6k_parkha.htm (6-K) — 13KB
- ea022687401ex10-1_parkha.htm (EX-10.1) — 23KB
- 0001213900-25-001616.txt ( ) — 38KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Park Ha Biological Technology Co., Ltd. Date: January 7, 2025 By: /s/ Xiaoqiu Zhang Name: Xiaoqiu Zhang Title: Chief Executive Officer 2